首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

市場調查報告書

商品編碼

1542871

全球乳房病變定位方法市場 - 2024-2031

Global Breast Lesion Localization Methods Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球乳房病變定位市場達3.6387億美元，預計2031年將達到7.9515億美元，2024-2031年預測期間複合年成長率為10.5%。

乳房病灶定位方法是手術前的程序，將放射性同位素、磁示蹤劑和電線等定位裝置插入檢測到癌症的部位，以便在手術切除時定位不可觸及的病灶。

乳房病灶定位方法程序是根據病灶類型及其位置，使用超音波、磁振造影 (MRI) 或乳房 X 光攝影等手術導引系統進行。隨著乳房病變的早期檢測，高達 50% 的腫瘤切除術和外科活體組織切片手術中必須進行定位程序，以確保準確切除目標病變。

市場動態：

驅動程式和限制

乳癌發生率增加

女性乳癌發生率的增加是全球乳房病變定位方法市場的主要促進因素。定位步驟確保外科醫師在手術過程中能夠準確識別和切除病灶。

例如，根據世界癌症研究基金會的數據，2022 年女性乳癌新增病例為 2,296,840 例。

每個國家都有大量乳癌患者，這提高了在地化的需求。例如，中國有超過 357,161 人患有乳癌，而美國有近 274、375 人患有乳癌。因此，乳癌患者數量的增加可能會促進市場成長。

先進技術成本高

先進的定位方法，例如放射性種子定位（RSL）和磁性種子定位（MSL），通常需要使用昂貴的專用設備。除了初始投資之外，這些技術可能還需要持續維護、專用設備和材料，這會增加整體成本。這可能會給醫療保健提供者帶來經濟負擔。

細分市場分析

全球乳房病變定位市場根據方法、設備和區域進行細分。

有線引導定位 (WGL) 領域預計將主導市場佔有率

線導本地化佔有最大的市場佔有率，預計在預測期內仍將佔據主導地位。這可以歸因於其成立較早和最終用戶的採用率較高。這種定位提供了病變的精確定位，尤其是微小或難以使用其他方法可視化的病變。

導絲定位是一種成熟且常用的乳房手術指導方法，具有悠久的成功歷史。該程序受到良好監管，具有較高的安全性和有效性，有助於確保其持續使用和採用。因此，上述因素預計將保持該細分市場的市場佔有率。

市場地域佔有率

北美預計將在乳房病變定位市場佔有率中佔據重要地位

北美在全球乳房病變定位方法市場中佔有相當大的佔有率，這主要歸因於該地區乳癌的高盛行率等因素。它擁有廣泛的患者群體和重要的醫療公司。

此外，美國等已開發地區的認知度較高、醫療保健支出較高、研究設施和實驗室的存在、該地區大多數知名企業開展的廣泛研究活動以及先進醫療技術的早期採用有助於推動區域市場。

例如，根據美國疾病管制與預防中心2022年的報告，2021年女性新增乳癌病例為272,454例，2022年有42,211名女性死於乳癌。

此外，根據美國癌症協會的數據，預計到 2024 年，女性中將診斷出約 310,720 例新的侵襲性乳癌病例，並且將診斷出約 56,500 例新的乳管原位癌 (DCIS) 病例。因此，乳癌病例數量的增加預計將增加對定位方法的需求，從而使該地區處於主導地位。

Breast Lesion Localization Methods procedure is carried out using surgical guidance systems such as ultrasound, Magnetic Resonance Imaging (MRI), or mammography, depending on the type of lesion and its location. With earlier detection of breast lesions, localization procedures have become necessary in up to 50% of all lumpectomy and surgical biopsy procedures to ensure accurate removal of the target lesion.

Market Dynamics: Drivers & Restraints

Increasing incidence of breast cancer

The increasing incidences of breast cancer among women are the predominant driving factor of the global market for breast lesion localization methods. The localization step ensures that the surgeon can accurately identify and excise the lesion during the surgery.

For instance, according to the World Cancer Research Fund International, it is stated that there were 2,296,840 new cases of breast cancer in 2022 among women.

Every country contains a large number of breast cancer patients which is raising the need for localization. For instance, China accounts for over 357,161 individuals suffering from breast cancer and the U.S. accounts for almost 274, 375 individuals with breast cancer. Thus, the increasing number of individuals with breast cancer could raise the market growth.

High cost of advanced technologies

Advanced localization approaches, such as radioactive seed localization (RSL) and magnetic seed localization (MSL), often require the use of costly specialized equipment. Beyond the initial investment, these technologies may necessitate ongoing maintenance, specialized equipment, and materials, which increases the entire cost. This may cause a financial burden on healthcare providers.

Market Segment Analysis

The global breast lesion localization market is segmented based on method, devices and region.

Wire-Guided Localization (WGL) segment is expected to dominate the market share

The wire-guided localization share holds the most significant market share and is expected to remain dominant over the forecast period. It can be attributed to its early establishment and higher adoption rate among end-users. This localization provides precise localization of lesions, especially lesions that are tiny or difficult to visualize using other methods.

Wire-guided localization is a well-established and commonly used approach for directing breast surgery, with a long history of success. The procedure is well-regulated and has a high safety and efficacy profile, which helps to ensure its continued use and adoption. Thus, the above factors are expected to hold the segment in the market share.

Market Geographical Share

North America is expected to hold a significant position in the breast lesion localization market share

North America holds a substantial share of the global breast lesion localization methods market, and it is primarily attributed to factors such as the high prevalence of breast cancer in the region. It has a broad base of the patient population and the presence of significant medical companies.

Moreover, the higher awareness in developed areas such as the U.S., high healthcare expenditure, the presence of research facilities and labs, the extensive research activities undertaken by a majority of prominent players in the area, and the early adoption of advanced medical technologies help propel the regional market.

For instance, according to the Centers for Disease Control and Prevention report in 2022, 272,454 new breast cancers were reported in females in 2021, and in 2022, 42,211 females died from breast cancer.

Additionally, according to the American Cancer Society, Inc., it is estimated that about 310,720 new cases of invasive breast cancer will be diagnosed in women in 2024, and about 56,500 new cases of ductal carcinoma in situ (DCIS) will be diagnosed. Thus, the increasing number of breast cancer cases is expected to increase the demand for localization methods, thus holding the region in the dominant position.

Market Segmentation

By Method

Wire-Guided Localization (WGL)

Magnetic Tracers

Electromagnetic Reflectors

Radio Guided Occult-Lesion Localization (ROLL)

Radioactive-Seed Localization (RSL)

Others

Breast Biopsy Marker Localization

Others

By Devices

Radioactive Seeds

Radar Reflectors

Magnetic Seeds

Radiofrequency Identification Tag Localizers (RFIDs)

Wires

Coils

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the market include Becton, Dickinson, and Company, Sterylab S.r.l., SOMATEX Medical Technologies GmbH, Argon Medical Devices, Hologic Inc., Cook Medical, Mammotome, Merit Medical Systems, Inc., Theragenics Corporation and Mermaid Medical among others.

Why Purchase the Report?

To visualize the global breast lesion localization market segmentation based on type, drug type, route of administration, distribution channel, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of breast lesion localization market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global breast lesion localization market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Method
3.2. Snippet by Devices
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing incidence of breast cancer
- 4.1.2. Restraints
  - 4.1.2.1. High cost of advanced technologies
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Method

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 6.1.2. Market Attractiveness Index, By Method
6.2. Wire-Guided Localization (WGL) *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Magnetic Tracers
6.4. Electromagnetic Reflectors
- 6.4.1. Radio Guided Occult-Lesion Localization (ROLL)
- 6.4.2. Radioactive-Seed Localization (RSL)
- 6.4.3. Others
6.5. Breast Biopsy Marker Localization
6.6. Others

7. By Devices

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
- 7.1.2. Market Attractiveness Index, By Devices
7.2. Radioactive Seeds*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Radar Reflectors
7.4. Magnetic Seeds
7.5. Radiofrequency Identification Tag Localizers (RFIDs)
7.6. Wires
7.7. Coils
7.8. Others

8. By Region

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
8.2. North America
- 8.2.1. Introduction
- 8.2.2. Key Region-Specific Dynamics
  - 8.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  - 8.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
- 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.2.3.1. The U.S.
  - 8.2.3.2. Canada
  - 8.2.3.3. Mexico
8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Key Region-Specific Dynamics
  - 8.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
- 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.3.4.1. Germany
  - 8.3.4.2. UK
  - 8.3.4.3. France
  - 8.3.4.4. Italy
  - 8.3.4.5. Spain
  - 8.3.4.6. Rest of Europe
8.4. South America
- 8.4.1. Introduction
- 8.4.2. Key Region-Specific Dynamics
  - 8.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
- 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.4.4.1. Brazil
  - 8.4.4.2. Argentina
  - 8.4.4.3. Rest of South America
8.5. Asia-Pacific
- 8.5.1. Introduction
- 8.5.2. Key Region-Specific Dynamics
  - 8.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
- 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.5.4.1. China
  - 8.5.4.2. India
  - 8.5.4.3. Japan
  - 8.5.4.4. South Korea
  - 8.5.4.5. Rest of Asia-Pacific
8.6. Middle East and Africa
- 8.6.1. Introduction
- 8.6.2. Key Region-Specific Dynamics
  - 8.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
8.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Becton, Dickinson, and Company *
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
10.2. Sterylab S.r.l.
10.3. SOMATEX Medical Technologies GmbH
10.4. Argon Medical Devices
10.5. Hologic Inc.
10.6. Cook Medical
10.7. Mammotome
10.8. Merit Medical Systems, Inc.
10.9. Theragenics Corporation
10.10. Mermaid Medical (*LIST NOT EXHAUSTIVE)